导航
| 统计阶段 | 收益率 | 同类排名 |
|---|---|---|
| 今年以来 | -13.91% | 4053/4773 |
| 近一周 | -1.58% | 2322/5465 |
| 近一月 | -8.11% | 4783/5421 |
| 近一季 | -18.68% | 4796/5231 |
| 近半年 | -22.10% | 4510/4920 |
| 近一年 | -9.01% | 3359/4394 |
| 近两年 | 27.96% | 2377/2954 |
| 近三年 | -0.56% | 1934/2253 |
| 成立以来 | 53.77% | - |
| 年份 | 年收益 | 1季度 | 2季度 | 3季度 | 4季度 |
| 2026 | - - |
4.13% 578/4961 |
- 3225/5312 |
- - |
- - |
| 2025 | 25.84% 1675/4813 |
-4.73% 3219/3635 |
-0.19% 2834/4076 |
35.05% 1006/4524 |
-2.01% 3064/4813 |
| 2024 | 0.95% 2036/3463 |
-2.32% 1348/2808 |
-7.71% 2115/3014 |
18.19% 1044/3129 |
-5.25% 2544/3463 |
| 2023 | -27.68% 2021/2656 |
-2.63% 2029/2280 |
-5.13% 1379/2385 |
-13.82% 2163/2515 |
-9.16% 2329/2655 |
| 2022 | -22.58% 1075/2207 |
-14.59% 976/1919 |
14.25% 203/2016 |
-15.45% 1295/2113 |
-6.17% 1982/2208 |
| 2021 | 48.49% 7/1822 |
-3.54% 812/1255 |
28.31% 51/1330 |
18.96% 57/1466 |
0.85% 1052/1822 |
| 2020 | 53.46% 150/1250 |
-6.33% 480/1028 |
15.25% 510/1067 |
15.09% 237/1164 |
23.51% 41/1184 |
| 2019 | 17.71% 681/1092 |
25.58% 453/754 |
-10.58% 743/804 |
-2.37% 695/850 |
7.36% 442/918 |
| 2018 | -38.86% 606/834 |
- - |
- - |
- - |
-9.00% 116/691 |
| 2017 | -2.12% 499/714 |
- - |
- - |
- - |
- - |
| 2016 | -15.97% 368/605 |
- - |
- - |
- - |
- - |
| 2015 | 35.97% 57/575 |
- - |
- - |
- - |
- - |
| 2014 | - - |
- - |
- - |
- - |
- - |
| 2013 | - - |
- - |
- - |
- - |
- - |
| 2012 | - - |
- - |
- - |
- - |
- - |
| 基金名称 | 最新净值 | 季增长率 |
| 万家中证港股通创新药ETF | 1.5896 | 28.31% |
| 港股医疗ETF | 1.4282 | 28.15% |
| 天弘恒生沪深港创新药精选50ETF | 0.8437 | 27.35% |
| 华富中证港股通创新药指数型发起式A | 1.1464 | 27.24% |
| 嘉实中证港股通创新药指数发起式C | 0.8441 | 26.80% |
| 中欧中证港股通创新药指数发起A | 1.5868 | 26.75% |
| 中欧中证港股通创新药指数发起C | 1.4370 | 26.67% |
| 永赢中证港股通医疗主题ETF发起联接A | 0.8762 | 26.58% |
| 华夏中证港股通医疗主题ETF发起式联接A | 0.8585 | 26.45% |
| 华夏中证港股通医疗主题ETF发起式联接C | 0.8568 | 26.39% |
| 新华中证环保产业指数 VS. 长安沪深300非周期A(740101) |